Recategorization Of Serous Fluid According To The International System For Reporting Serous Fluid Cytopathology: A Tertiary Care Center Study
International Journal of Drug Delivery Technology · 04.06.2026 · 16 (45s)
DOI: 10.25258/ijddt.16.45s.59 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Drug Delivery Technology, online erschienen am 04.06.2026. Verfasst von Yelda Vyas und 2 weiteren Autor:innen.
Abstract (Originalsprache)
Introduction
Serous effusion can be due to local or systemic pathology. Its study is very cost effective , minimally invasive and safe procedure. It serves as diagnostic tool for establishing diagnosis , for microbiological and biochemical testing and finding origin of malignancy. The present study was conducted at Balvir Singh Tomar Institute of Medical Sciences and Research, Jaipur with an aim to recategorize and diagnose serous fluids on the basis of TIS , which can potentially direct future modifications in terminology and management. Material and method We retrospectively reviewed 120 cytopathology cases of all peritoneal washings, ascitic, pleural and pericardial effusion cytology from February 2025 to March 2026. All cases were reclassified according to proposed TIS system into five categories.
Result
Before recategorization various terminologies were used by faculties in diagnosis, although no definite criteria were proposed for unsatisfactory category. After combining of these cases of inadequate sample of 29 cases (24.3%) and after recategorization only 18 (14.3%) cases were found to be inadequate. Out of 18 cases,1 case was found to have blood only. Maximum cases were found to be in benign effusion. 9(7.3%) cases were reported as atypical cells. 3(2.5%) cases found to be suspicious for malignancy and 6(4.9%) cases were of malignant effusion. Recategorization led to change in distribution of cases in all categories.
Conclusion
This is a retrospective study of serous fluid to reclassify them using criteria of TIS. Our results show that this system is robust, easily applicable and improves reporting of serous fluid samples. TIS is user friendly and appear to be a consistent methodology for standardized reporting.
Zitieren
APA
Vyas, Y., Sanwelka, M., & Bali, I. K. (2026). Recategorization Of Serous Fluid According To The International System For Reporting Serous Fluid Cytopathology: A Tertiary Care Center Study. International Journal of Drug Delivery Technology, 16(45s). https://doi.org/10.25258/ijddt.16.45s.59
Vancouver
Vyas Y, Sanwelka M, Bali IK. Recategorization Of Serous Fluid According To The International System For Reporting Serous Fluid Cytopathology: A Tertiary Care Center Study. International Journal of Drug Delivery Technology. 2026;16(45s). doi:10.25258/ijddt.16.45s.59
BibTeX
@article{Vyas2026,
author = {Vyas, Yelda and Sanwelka, Madhvi and Bali, Irbinder Kour},
title = {Recategorization Of Serous Fluid According To The International System For Reporting Serous Fluid Cytopathology: A Tertiary Care Center Study},
journal = {International Journal of Drug Delivery Technology},
year = {2026},
volume = {16},
number = {45s},
doi = {10.25258/ijddt.16.45s.59}
}
EUVIMED